Business Context and Reporting Period
This Form 8-K Current Report is filed by Imunon, Inc. (Nasdaq: IMNN) for the reporting period ending June 29, 2026. The filing addresses significant changes in executive leadership, specifically the departure of the interim Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Departure of Interim CFO: Jeffrey Church informed the Company of his intent to retire from the position of interim Chief Financial Officer, effective July 1, 2026. He served in this role since January 2026. The departure is due to retirement with no disagreements with management.
- Appointment of New Interim CFO: Effective July 1, 2026, Josh Blacher was appointed as the new interim Chief Financial Officer, principal financial officer, and principal accounting officer.
- Compensation Arrangements:
- Mr. Church will transition to a consulting role with a monthly retainer of $10,000, terminable upon 2 business days' notice.
- Mr. Blacher's services are provided through Danforth Health, Inc. under a master services agreement dated June 24, 2026, at a rate of $475 per hour.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of material risks and contingencies beyond the standard disclosure regarding the transition of financial leadership. The Company stated the transition is intended to be smooth.
Investor Verification Checklist
- Verify the effective date of the CFO transition (July 1, 2026) and the immediate impact on financial reporting timelines.
- Review the Master Services Agreement (Exhibit 10.1) for full terms regarding Mr. Blacher's engagement and potential termination clauses.
- Confirm the duration and scope of Mr. Church's consulting role to assess ongoing financial advisory costs.
- Check subsequent filings for the appointment of a permanent CFO, as both current and incoming officers are designated as "interim."